ABSTRACT Introduction Acute Respiratory Distress Syndrome (ARDS) is a heterogeneous
form of lung injury with severe hypoxemia and bilateral infiltrates after an inciting event that …

ARDS, first described in 1967, is the commonest form of acute severe hypoxemic respiratory
failure. Despite considerable advances in our knowledge regarding the pathophysiology of …

Acute respiratory distress syndrome (ARDS) is intricately linked with SARS-CoV-2-
associated disease severity and mortality, especially in patients with co-morbidities. Lung …

Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …

COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …

Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome historically
characterized by the presence of severe hypoxemia, high-permeability pulmonary edema …

Acute respiratory distress syndrome (ARDS) presents as an acute inflammatory lung injury
characterized by refractory hypoxemia and non-cardiac pulmonary edema. An estimated …

Host-directed therapeutics targeting immune dysregulation are considered the most
promising approach to address the unmet clinical need for acute lung injury (ALI)/acute …

Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …

Abstract Acute Respiratory Distress Syndrome (ARDS) can occur in critically ill people due
to COVID-19. These combinations of ARDS and COVID-19 are usually fatal, and the risk …